EUCTR2006-002698-38-BE进行中（未招募）不适用
STUDY OF THE EFFICACY AND SAFETY OF KALINOX® 170 BAR FOR THE PERFORMANCE OF CARE PROCEDURES IN CHILDREN WITH BURNS
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
入选标准
- •Child between 5 and 15 years of age burned since few days and who has to undergo at least three burn-care procedures per day.
- •·potentially mildly to moderately painful ·lasting for at least 15 minutes and for less than 30 minutes
- •·eligible to receive short-term prophylactic analgesic treatment
- •·for whom the consent form has been signed (parent and child)
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •- Child treated under general anaesthesia- Child physically or mentally incapable of responding to an assessment of his/her pain on a visual scale.
- •- Child suffering from moderate to severe pain when beginning the care procedure
- •- Exclusion criteria linked to the product
研究者
相似试验
进行中（未招募）
不适用
Study of the efficacy and safety of Kalinox 170 bar for the performance of care procedures in children with burnsEstudio de la eficacia y tolerancia del Kalinox 170 bar en los cuidados para el tratamiento de ninos quemados - Kalinox 170 bar for care procedures in children with burnsEUCTR2006-002698-38-ESAIR LIQUIDE Santé INTERNATIONA150
撤回
3 期
Study of the Efficacy and Safety of Kalinox® 170 Bar for the Performance of Care Procedures in Children With BurnsBurnsNCT00643357Air Liquide Santé International
进行中（未招募）
不适用
Etude de l'efficacité du Kalinox 170 bar lors de la réalisation de biopsies de lésions focales hépatiques - Efficacité de kalinox lors de biopsies hépatiquesEUCTR2006-004203-19-FRAIR LIQUIDE Santé INTERNATIONA
招募中
不适用
Trials of KML001 in patients with non-Hodgkin's lymphomaNeoplasmsKCT0000737Komipharm51
已完成
不适用
A Phase I Study of KOMINOX (KML001) for Refractory or Recurrent Solid TumorsKCT0003574Samsung Medical Center42